Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Medtronic acquires heart valve firm for 325m dollars

Medtronic acquires heart valve firm for 325m dollars

25th February 2009

Medtronic has acquired a firm for $325 million (223.56 million pounds) that develops transcatheter heart valve technologies.

The privately-held company – Ventor Technolgies – was founded in 2004 and is based in Israel, dedicated to developing minimally-invasive replacement aortic valves.

Currently, patients with diseases affecting this part of the body receive surgery, but many are unable to undergo the procedure because of their deteriorating health.

The merger will add two technologies to Medtronic’s portfolio and both offer clinical benefits to those candidates whose wellbeing would be put at risk if they were operated on.

Bill Hawkins, chairman and chief executive of Medtronic, commented on the aquistion: “Ventor Technologies and our strengths in research and development, operations, medical education and market development will improve patient outcomes.”

He further added it would also widen the choice surgeons and cardiologists have when considering which treatment would be best to adopt for sufferers.

The global technology company Medtronic also recently revealed it has signed an agreement to takeover CoreValve, which also develops transcatheter, transfemoral aortic valve replacement products.

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.